본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
(grant 수정 필요)Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation 김수열
(암분자생물학연구과)
김수열:강민규:강준희, 심인애, 한수지, 장현철, 이호, Do Y. Seong, Sang W. Kang. (grant 수정 필요)Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023-07-26; 2023; 24(15):11969~. IF 5.6 (2022)
강민규
(암분자생물학연구과)
(grant 수정 필요)Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: implication to cancer control 김선영
(암AI디지털헬스학과)
김선영:Cham Thi Nguyen:최윤정. (grant 수정 필요)Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: implication to cancer control CANCER MEDICINE. 2023-07-25; 2023; 12(16):17418~17427. IF 4 (2022)
Cham Thi Nguyen
Individual and joint effect of socioeconomic status and lifestyle factors on cancer in Korea 오진경
(암관리학과)
오진경:Chi Lan Tran:최귀선, 김선영. Individual and joint effect of socioeconomic status and lifestyle factors on cancer in Korea CANCER MEDICINE. 2023-07-25; 2023; 12(16):17389~17402. IF 4 (2022)
Chi Lan Tran
Alteration of Metabolic Syndrome Is Associated with the Decreased Risk of Colorectal Cancer 최윤진
(소화기내과분과)
최윤진, Dong Ho Lee:Eun Hyo Jin:. Alteration of Metabolic Syndrome Is Associated with the Decreased Risk of Colorectal Cancer JOURNAL OF CLINICAL MEDICINE. 2023-07-25; 2023; 12(15):4889~. IF 3.9 (2022)
Eun Hyo Jin
Translational mRNA profiling analysis of pseudopalisading cells in bevacizumab resistance of GBM 김성수
(암의생명과학과)
박종배
(암의생명과학과)
김성수, 박종배, Do-Hyun Nam:김예진, 김태훈:. Translational mRNA profiling analysis of pseudopalisading cells in bevacizumab resistance of GBM ADVANCED THERAPEUTICS. 2023-07-21; 2023; 6(11):2300148~. IF 4.6 (2022)
김예진
(국립암센터국제암대학원대학교산학협력단)
김태훈
(생물정보연구과)
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis Yun Mi Yu, Young-Mi Ah
Yun Mi Yu, Young-Mi Ah:전진영, JongSung Hahn:Min Jung Geum, Hyun Woo Lee, Jaekyu Shin, Woo-Young Chung. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis THROMBOSIS JOURNAL. 2023-07-14; 2023; 21(1):76~. IF 3.1 (2022)
전진영
(약무과)
Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation Sang Joon Park, Chul-Kee Park
Sang Joon Park, Chul-Kee Park:도윤식, Byeong Cheol Lee:Hyeong Cheol Moon, Kyung Min Kim, Ho Kang, Eun Jung Lee, Min-Sung Kim, Jin Wook Kim, Yong Hwy Kim. Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY. 2023-07-13; 2023; 19(1):15~25. IF 3 (2022)
도윤식
(신경외과)
(Grant 수정 필요)Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance 박찬이
(생물정보연구과)
한지연1
(폐암센터)
박찬이, 한지연:Jihyun Kim, 김선신:박석연, 이건국, 임근영, 김진영, 황정아, 유남희, 강은혜, 황미화, 송보람. (Grant 수정 필요)Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance CANCERS. 2023-07-11; 2023; 15(14):3568~. IF 5.2 (2022)
김선신
(표적치료연구과)
Myelomeningocele: The Evolution of Care over the last 50 years 왕규창
(신경외과)
왕규창:Robin M Bowman, Ji Yeoun Lee:. Myelomeningocele: The Evolution of Care over the last 50 years CHILDS NERVOUS SYSTEM. 2023-07-07; 2023; 39(10):2829~2845. IF 1.4 (2022)
Robin M Bowman, Ji Yeoun Lee
(Grant 수정 요청)Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data Sun Jung Kim
Sun Jung Kim:한규태:. (Grant 수정 요청)Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data INTERNATIONAL JOURNAL OF PUBLIC HEALTH. 2023-07-06; 2023; 68:1606000~. IF 4.6 (2022)
한규태
(암관리정책부)